Home > Business models, Collaboration, Life Sciences, Report > The pharmaceutical industry is seeking stronger ties with academia in a bid to speed up drug development

The pharmaceutical industry is seeking stronger ties with academia in a bid to speed up drug development

Drug Buddies

From Nature:

“When pharmaceutical company Pfizer announced on 8 June that it is teaming up with eight research institutions in the Boston area to hunt for candidate drugs, the news was cheered from all sides. The governor of Massachusetts, Deval Patrick, praised the US$100-million, five-year deal for the jobs it would bring to the region. Eric Buehrens, interim chief executive of Beth Israel Deaconess Medical Center, one of the academic partners, extolled the benefits to scientific research. Pfizer says that the partnerships will accelerate development of the next generation of drugs…”

READ FULL ARTICLE [web]
Pfizer forms Boston medical partnership, plans $100M investment [web]
GSK Report: What Big Pharma seeks in Developing Partnerships with Academia [web, pdf]

Advertisements
  1. No comments yet.
  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: